BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28230172)

  • 21. Claudin 1 overexpression increases invasion and is associated with aggressive histological features in oral squamous cell carcinoma.
    Dos Reis PP; Bharadwaj RR; Machado J; Macmillan C; Pintilie M; Sukhai MA; Perez-Ordonez B; Gullane P; Irish J; Kamel-Reid S
    Cancer; 2008 Dec; 113(11):3169-80. PubMed ID: 18991282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. UBE2S associated with OSCC proliferation by promotion of P21 degradation via the ubiquitin-proteasome system.
    Yoshimura S; Kasamatsu A; Nakashima D; Iyoda M; Kasama H; Saito T; Takahara T; Endo-Sakamoto Y; Shiiba M; Tanzawa H; Uzawa K
    Biochem Biophys Res Commun; 2017 Apr; 485(4):820-825. PubMed ID: 28257844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High expression of EZH2 is associated with tumor proliferation and prognosis in human oral squamous cell carcinomas.
    Kidani K; Osaki M; Tamura T; Yamaga K; Shomori K; Ryoke K; Ito H
    Oral Oncol; 2009 Jan; 45(1):39-46. PubMed ID: 18619895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased expression of kallikrein-related peptidase 13: possible contribution to metastasis of human oral cancer.
    Ishige S; Kasamatsu A; Ogoshi K; Saito Y; Usukura K; Yokoe H; Kouzu Y; Koike H; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
    Mol Carcinog; 2014 Jul; 53(7):557-65. PubMed ID: 23371469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low miR-143/miR-145 Cluster Levels Induce Activin A Overexpression in Oral Squamous Cell Carcinomas, Which Contributes to Poor Prognosis.
    Bufalino A; Cervigne NK; de Oliveira CE; Fonseca FP; Rodrigues PC; Macedo CC; Sobral LM; Miguel MC; Lopes MA; Paes Leme AF; Lambert DW; Salo TA; Kowalski LP; Graner E; Coletta RD
    PLoS One; 2015; 10(8):e0136599. PubMed ID: 26317418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ERBB2 gene amplification in oral squamous cell malignancies: a correlation with tumor progression and gene expression.
    Chu F; Feng Q; Qian Y; Zhang C; Fang Z; Shen G
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jul; 112(1):90-5. PubMed ID: 21531597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel mechanism of aberrant ZIP4 expression with zinc supplementation in oral tumorigenesis.
    Ishida S; Kasamatsu A; Endo-Sakamoto Y; Nakashima D; Koide N; Takahara T; Shimizu T; Iyoda M; Shiiba M; Tanzawa H; Uzawa K
    Biochem Biophys Res Commun; 2017 Jan; 483(1):339-345. PubMed ID: 28017725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ANGPTL3 is a novel biomarker as it activates ERK/MAPK pathway in oral cancer.
    Koyama T; Ogawara K; Kasamatsu A; Okamoto A; Kasama H; Minakawa Y; Shimada K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K
    Cancer Med; 2015 May; 4(5):759-69. PubMed ID: 25644496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyaluronan-mediated motility: a target in oral squamous cell carcinoma.
    Yamano Y; Uzawa K; Shinozuka K; Fushimi K; Ishigami T; Nomura H; Ogawara K; Shiiba M; Yokoe H; Tanzawa H
    Int J Oncol; 2008 May; 32(5):1001-9. PubMed ID: 18425326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High prevalence of decreased expression of KAI1 metastasis suppressor in human oral carcinogenesis.
    Uzawa K; Ono K; Suzuki H; Tanaka C; Yakushiji T; Yamamoto N; Yokoe H; Tanzawa H
    Clin Cancer Res; 2002 Mar; 8(3):828-35. PubMed ID: 11895916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Up-regulation of miR-187 modulates the advances of oral carcinoma by targeting BARX2 tumor suppressor.
    Lin SC; Kao SY; Chang JC; Liu YC; Yu EH; Tseng SH; Liu CJ; Chang KW
    Oncotarget; 2016 Sep; 7(38):61355-61365. PubMed ID: 27542258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Network-based analysis of calcium-binding protein genes identifies Grp94 as a target in human oral carcinogenesis.
    Nomura H; Uzawa K; Yamano Y; Fushimi K; Ishigami T; Kato Y; Saito K; Nakashima D; Higo M; Kouzu Y; Ono K; Ogawara K; Shiiba M; Bukawa H; Yokoe H; Tanzawa H
    Br J Cancer; 2007 Sep; 97(6):792-801. PubMed ID: 17726464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling.
    Yang MH; Lin BR; Chang CH; Chen ST; Lin SK; Kuo MY; Jeng YM; Kuo ML; Chang CC
    Oncogene; 2012 May; 31(19):2401-11. PubMed ID: 21927029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NOTCH3 Is Induced in Cancer-Associated Fibroblasts and Promotes Angiogenesis in Oral Squamous Cell Carcinoma.
    Kayamori K; Katsube K; Sakamoto K; Ohyama Y; Hirai H; Yukimori A; Ohata Y; Akashi T; Saitoh M; Harada K; Harada H; Yamaguchi A
    PLoS One; 2016; 11(4):e0154112. PubMed ID: 27124156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SIPA1 promotes invasion and migration in human oral squamous cell carcinoma by ITGB1 and MMP7.
    Takahara T; Kasamatsu A; Yamatoji M; Iyoda M; Kasama H; Saito T; Takeuchi S; Endo-Sakamoto Y; Shiiba M; Tanzawa H; Uzawa K
    Exp Cell Res; 2017 Mar; 352(2):357-363. PubMed ID: 28237246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishing Fascin over-expression as a strategic regulator of neoplastic aggression and lymph node metastasis in oral squamous cell carcinoma tumor microenvironment.
    Routray S; Kheur S; Chougule HM; Mohanty N; Dash R
    Ann Diagn Pathol; 2017 Oct; 30():36-41. PubMed ID: 28965626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-1 receptor antagonist (IL1RN) is associated with suppression of early carcinogenic events in human oral malignancies.
    Shiiba M; Saito K; Yamagami H; Nakashima D; Higo M; Kasamatsu A; Sakamoto Y; Ogawara K; Uzawa K; Takiguchi Y; Tanzawa H
    Int J Oncol; 2015 May; 46(5):1978-84. PubMed ID: 25738940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of TMOD1 is associated with enhanced regional lymph node metastasis in human oral cancer.
    Suzuki T; Kasamatsu A; Miyamoto I; Saito T; Higo M; Endo-Sakamoto Y; Shiiba M; Tanzawa H; Uzawa K
    Int J Oncol; 2016 Feb; 48(2):607-12. PubMed ID: 26718916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A loss of profilin-1 in late-stage oral squamous cell carcinoma.
    Adami GR; O'Callaghan TN; Kolokythas A; Cabay RJ; Zhou Y; Schwartz JL
    J Oral Pathol Med; 2017 Aug; 46(7):489-495. PubMed ID: 27862305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatty-acid-binding protein 5 promotes cell proliferation and invasion in oral squamous cell carcinoma.
    Fang LY; Wong TY; Chiang WF; Chen YL
    J Oral Pathol Med; 2010 Apr; 39(4):342-8. PubMed ID: 20040021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.